🇺🇸 FDA
Pipeline program

Dexmedetomidine

2022ZH0218

Unknown small_molecule completed

Quick answer

Dexmedetomidine for Anxiety is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Anxiety
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials